Alexis Guédon: Cancer-Associated Upper-Extremity Deep Vein Thrombosis
Alexis Guédon, Junior Deputy Editor at the European Journal of Preventive Cardiology, shared on LinkedIn about a recent article he and his colleagues co-authored, published in JACC Journals, adding:
“Upper-extremity deep vein thrombosis in cancer is sometimes viewed primarily as a catheter-related complication with a relatively low risk of recurrence.
In JACC Journals: CardioOncology, we report findings from 5,195 patients enrolled in the international RIETE registry, including 2,210 with active cancer.
We found that:
- Cancer was associated with higher risks of recurrent venous thromboembolism and bleeding.
- Risk differed substantially by cancer site: lung cancer had the highest recurrence risk, whereas genitourinary cancers had the highest bleeding risk.
- After anticoagulation discontinuation, the 2-year recurrence risk reached 17.2% in patients with lung cancer.
- Longer anticoagulation was associated with a lower risk of recurrence after treatment discontinuation, although these observational association should not be interpreted as causal.
These results suggest that cancer-associated upper-extremity deep vein thrombosis is more than a mechanical catheter-related complication.
Tumor biology appears to influence the balance between thrombosis and bleeding, supporting careful reassessment before anticoagulation is discontinued.
A study led by Olivier Espitia and Manuel Monreal, with the RIETE Investigators.”
Title: Upper Extremity Deep Vein Thrombosis in Cancer Patients: Clinical Course by Cancer Site
Authors: Olivier Espitia, Alexis F. Guedon, Emma Courouve, Benjamin Brenner, Juan José López-Núñez, Romain Chopard, Alicia Lorenzo, Patricia Sigüenza, Son Truong Nguye
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 03:53Nahrwan Masaoodi: Iron Deficiency Can Exist Without Anemia
-
Sep 29, 2026, 03:38Muhammad Yousaf: Iron Deficiency Beyond Diet
-
Sep 29, 2026, 03:21Parvez Ahmed Chowdhury: Synthesizing Aspirin in the Organic Chemistry Lab
-
Sep 29, 2026, 03:12Ahmed Hamandi: Building the Future of Hematopoietic Transplantation in Iraq
-
Sep 29, 2026, 03:09M V Chandrakanth: Aspirin in CRC – Old Drug, New Precision Oncology?
-
Sep 29, 2026, 03:07Caroline Pothet: Advancing Treatment Development in Sickle Cell Disease and Thalassaemia
-
Sep 29, 2026, 02:53Astha Jain: Thalassemia Care Through a Public Health Lens
-
Sep 29, 2026, 02:50Emma Groarke: Starting a New Career Path in Homeland
-
Sep 28, 2026, 19:14Aditya Sharma: An Outstanding Start to the Final Day of VSS 2026!